Tesamorelin vs AOD 9604: Mechanisms, Research, and Key Differences
In different preclinical models, Tesamorelin and AOD 9604 have been explored for their possible roles in lipid metabolism. Researchers have observed that Tesamorelin signals the pituitary gland to release growth hormone by binding to the GHRH receptor [1]. AOD 9604, by contrast, is studied for direct effects at the adipocyte level in research preclinical models […]